Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Core Symptom of Schizophrenia Eliminated
Friday, February 19, 2016
Team uses chemical compound to restore affected brain regions; findings could lead to new treatment strategies.

Structure of ‘Smart’ Nanogels at Air/Water Interface Revealed
Friday, February 19, 2016
Findings may lead to better drug administration practices than current methods.

Spero Therapeutics Announces $30 Million Series B Preferred Financing
Wednesday, February 10, 2016
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.

Synthesis and Kilo Lab Extensions to US facility
Tuesday, February 09, 2016
Company builds a new synthesis laboratory and a kilo lab for US facility.

Biogen Joins Pioneering Target Validation Collaboration
Tuesday, February 09, 2016
The Centre for Therapeutic Target Validation welcomes new member Biogen, expanding its efforts to accelerate drug discovery research.

Keeping Tumor Growth at Bay
Friday, February 05, 2016
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.

Nordic Nanovector Awarded NOK 15M
Friday, February 05, 2016
Nordic Nanovector ASA is pleased to announce the award of a up to NOK 15 million grant from the Research Council of Norway’s User-driven Research-based Innovation programme to support the research and development of novel targeted therapeutics for leukemia and non-Hodgkin Lymphoma.

Future of Medicine Could be Found in a Tiny Crystal Ball
Thursday, February 04, 2016
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.

DTRA Awards $9.7M Contract for Drug Development
Thursday, February 04, 2016
The Defense Threat Reduction Agency (DTRA) has awarded Emory University a $9.7M contract to develop drugs to treat infections caused by emerging and man-made viral threats. Under the contract, the DTRA funds will be used to advance the development of the lead drug candidate.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 4248
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!